Category Archives: Global

Making the Most of Disruptive Digital Technologies

Peter Houston looks at the pharma marketing takeaways from last week’s Digital Innovation Summit.
Also posted in E-Media, Europe, Events, Marketing, multimedia, Op-Ed, social media, Technology | Tagged , , , | Leave a comment

EGA Calls for Removal of Barriers to Generics in Europe

Adrian van den Hoven, Director General of the European Generics Association (EGA), this week called for the removal of barriers to generic medicines across the European Union.
Also posted in Europe, Events, Regulatory | Tagged , , , , | Leave a comment

Biotech Industry Calls for Pan-European Tax Incentives

Europe’s biotech industry body, EuropaBio, has launched a report urging European governments to remain committed to biotech research, development and innovation (RDI) incentives, following release of the European Commission’s (EC) 2014 Innovation Scoreboard.
Also posted in Biotech, Europe, R&D, Regulatory | Tagged , , , , , | Leave a comment

Adaptive Licensing: The Start of a Slow Revolution in Europe

By Peter O’ Donnell. So at last it’s happened. Adaptive licensing has leapt from the pages of learned journals into the real world of European regulation. Is this the beginning of the end of binary decision-making on the merits of a new medicine? Has a half-century of the “yes/no” authorization process peaked, to be replaced […]
Also posted in Europe, Guest Blog, Op-Ed, R&D, Regulatory, Safety | Tagged , , , , , | Leave a comment

Outlook “Gloomy” for TB Investment

The approval last year of Johnson & Johnson’s (J&J) treatment for tuberculosis (bedaquiline) — at the time the first TB drug approval in 40 years — “remains an exception to the generally gloomy outlook” for investment in TB R&D, writes Andrew Ward in this week’s Financial Times.
Also posted in Emerging Markets, Strategy | Tagged , , , , , | Leave a comment
  • Categories

  • Meta